Bivalent binding of IgA1 to FcαRI suggests a mechanism for cytokine activation of IgA phagocytosis

Journal of Molecular Biology

Volumn 327, Issue 3, 2003, Pages 645-657

  Herr, Andrew B ^a   White, Clinton L ^a,b   Milburn, Christina ^a,c   Wu, Carol ^a,d   Bjorkman, Pamela J ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b Campbell Alliance   (United States)

^c Medarex Inc   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analytical ultracentrifugation; Fc RI; IgA1; Stoichiometry; Surface plasmon resonance

Indexed keywords

CYTOKINE; DIMER; FC ALPHA RECEPTOR I; FC RECEPTOR; HISTIDINE; IMMUNOGLOBULIN A1; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; BINDING SITE; DISSOCIATION CONSTANT; ELECTRICITY; ENERGY; GEL FILTRATION; MOLECULE; PH; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTON TRANSPORT; STOICHIOMETRY; SURFACE PLASMON RESONANCE; THERMODYNAMICS; ULTRACENTRIFUGATION;

EID: 0037470618     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00149-9     Document Type: Article

References (57)

1. Morton H.C., van Egmond M., van de Winkel J.G. Structure and function of human IgA Fc receptors (FcαR). Crit. Rev. Immunol. 16:1996;423-440.
2. Maliszewski C.R., March C.J., Schoenborn M.A., Gimpel S., Shen L. Expression cloning of a human Fc receptor for IgA. J. Expt. Med. 172:1990;1665-1672.
3. Monteiro R.C., Kubagawa H., Cooper M.D. Cellular distribution, regulation, and biochemical nature of an Fcα receptor in humans. J. Expt. Med. 171:(3):1990;597-613.
4. van Egmond M., van Garderen E., van Spriel A.B., Damen C.A., van Amersfoort E.S., van Zandbergen G., et al. FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nature Med. 6:2000;680-685.
5. Launay P., Grossetete B., Arcos-Fajardo M., Gaudin E., Torres S.P., Beaudoin L., et al. Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J. Expt. Med. 191:2000;1999-2009.
6. Stockmeyer B., Dechant M., van Egmond M., Tutt A.L., Sundarapandiyan K., Graziano R.F., et al. Triggering Fcα-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy. J. Immunol. 165:2000;5954-5961.
7. Lang M.L., Shen L., Wade W.F. γ-Chain dependent recruitment of tyrosine kinases to membrane rafts by the human IgA receptor FcαR. J. Immunol. 163:1999;5391-5398.
8. Morton H.C., van den Herik-Oudijk I.E., Vossebeld P., Snijders A., Verhoeven A.J., Capel P.J., et al. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/FcR gamma chain association. J. Biol. Chem. 270:1995;29781-29787.
9. Wende H., Colonna M., Ziegler A., Volz A. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm. Genome. 10:1999;154-160.
10. Shen L. Receptors for IgA on phagocytic cells. Immunol. Res. 11:1992;273-282.
11. Carayannopoulos L., Hexham J.M., Capra J.D. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Cα2 and Cα3 in human IgA1. J. Expt. Med. 183:(4):1996;1579-1586.
12. 3 domain interface of IgA essential for interaction with the human Fcα receptor (FcαR) CD89. J. Biol. Chem. 274:(33):1999;23508-23514.
13. Burmeister W.P., Huber A.H., Bjorkman P.J. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature. 372:1994;379-383.
14. Garman S.C., Wurzburg B.A., Tarchevskaya S.S., Kinet J.P., Jardetzky T.S. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα Nature. 406:2000;259-266.
15. Sondermann P., Huber R., Oosthuizen V., Jacob U. The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature. 406:2000;267-273.
16. Wines B.D., Hulett M.D., Jamieson G.P., Trist H.M., Spratt J.M., Hogarth P.M. Identification of residues in the first domain of human Fcα receptor essential for interaction with IgA. J. Immunol. 162:1999;2146-2153.
17. Wines B.D., Sardjono C.T., Trist H.M., Lay C.S., Hogarth P.M. The interaction of FcαRI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J. Immunol. 166:2001;1781-1789.
18. Chapman T.L., Heikema A.P., West A.P., Bjorkman P.J. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity. 13:2000;727-736.
19. Weisbart R.H., Kacena A., Schuh A., Golde D.W. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature. 332:1988;647-648.
20. Bracke M., Lammers J.W., Coffer P.J., Koenderman L. Cytokine-induced inside-out activation of FcαR (CD89) is mediated by a single serine residue (S263) in the intracellular domain of the receptor. Blood. 97:2001;3478-3483.
21. Nikolova E.B., Russell M.W. Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells. J. Leukoc. Biol. 57:1995;875-882.
22. Atkin J.D., Pleass R.J., Owens R.J., Woof J.M. Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly. J. Immunol. 157:1996;156-159.
23. Keown M.B., Ghirlando R., Young R.J., Beavil A.J., Owens R.J., Perkins S.J., et al. Hydrodynamic studies of a complex between the Fc fragment of human IgE and a soluble fragment of the FcεRIα chain. Proc. Natl Acad. Sci. USA. 92:1995;1841-1845.
24. Huber A.H., Kelley R.F., Gastinel L.N., Bjorkman P.J. Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc. J. Mol. Biol. 230:1993;1077-1083.
25. Hummel J.P., Dreyer W.J. Measurement of protein-binding phenomena by gel-filtration. Biochim. Biophys. Acta. 63:1962;530-532.
26. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78:2000;1606-1619.
27. Stafford W.F. Sedimentation boundary analysis of interacting systems: use of the apparent sedimentation coefficient distribution function. Schuster T.M., Laue T.M. Modern Analytical Ultracentrifugation: Acquisition and Interpretation of Data for Biological and Synthetic Polymer Systems. 1994;119-137 Birkhauser, Boston.
28. Bradshaw J.M., Waksman G. Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: application to the interaction of the Src SH2 domain with a high-affinity tyrosyl phosphopeptide. Biochemistry. 37:1998;15400-15407.
29. Stryer L. Biochemistry. 3rd edit. 1988;W. H. Freeman and Company, New York.
30. Grucza R.A., Bradshaw J.M., Mitaxov V., Waksman G. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase. Biochemistry. 39:2000;10072-10081.
31. Record M.T. Jr, Anderson C.F. Interpretation of preferential interaction coefficients of nonelectrolytes and of electrolyte ions in terms of a two-domain model. Biophys. J. 68:1995;786-794.
32. Record M.T. Jr, Lohman M.L., De Haseth P. Ion effects on ligand-nucleic acid interactions. J. Mol. Biol. 107:1976;145-158.
33. Boehm M.K., Woof J.M., Kerr M.A., Perkins S.J. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. J. Mol. Biol. 286:1999;1421-1447.
34. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-Å resolution. Biochemistry. 20:1981;2361-2370.
35. Kucik D.F., Dustin M.L., Miller J.M., Brown E.J. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J. Clin. Invest. 97:1996;2139-2144.
36. Shen L., Collins J.E., Schoenborn M.A., Maliszewski C.R. Lipopolysaccharide and cytokine augmentation of human monocyte IgA receptor expression and function. J. Immunol. 152:1994;4080-4086.
37. Stewart W.W., Mazengera R.L., Shen L., Kerr M.A. Unaggregated serum IgA binds to neutrophil FcαR at physiological concentrations and is endocytosed but cross-linking is necessary to elicit a respiratory burst. J. Leukoc. Biol. 56:1994;481-487.
38. Launay P., Patry C., Lehuen A., Pasquier B., Blank U., Monteiro R.C. Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRγ association and protects against degradation of bound ligand. J. Biol. Chem. 274:1999;7216-7225.
39. Mukherjee S., Ghosh R.N., Maxfield F.R. Endocytosis. Physiol. Rev. 77:1997;759-803.
40. Carayannopoulos L., Max E.E., Capra J.D. Recombinant human IgA expressed in insect cells. Proc. Natl Acad. Sci. USA. 91:1994;8348-8352.
41. Bebbington C.R., Hentschel C.C.G. DNA Cloning. 1987;IRL, Oxford.
42. Gastinel L.N., Simister N.E., Bjorkman P.J. Expression and crystallization of a soluble and functional form of the Fc receptor related to class I histocompatibility molecules. Proc. Natl Acad. Sci. USA. 89:1992;632-642.
43. Liu Y.-S.V., Low T.L.K., Infante A., Putnam F.W. Complete covalent structure of a human IgA1 immunoglobulin. Science. 193:1976;1017-1019.
44. Gill S.C., von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326.
45. Philo J.S. Measuring sedimentation, diffusion, and molecular weights of small molecules by direct fitting of sedimentation velocity concentration profiles. Schuster T.M., Laue T.M. Modern Analytical Ultracentrifugation. 1994;156-170 Birkhauser, Boston.
46. Cantor C.R., Schimmel P.R. Biophysical Chemistry Part III: The Behaviour of Biological Macromolecules. 1980;W. H. Freeman and Co, New York.
47. Johnson M.L., Correia J.J., Yphantis D.A., Halvorson H.R. Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques. Biophys. J. 36:1981;575-588.
48. Laue T.M., Shah B.D., Ridgeway T.M., Pelletier S.M. Computer-aided interpretation of sedimentation data for proteins. Harding S.E., Rowe A.J., Horton J.C. Analytical Ultracentrifugation in Biochemistry and Polymer Science. 1992;90-125 Royal Society of Chemistry, London.
49. Jenkins N., Parekh R.B., James D.C. Getting the glycosylation right: implications for the biotechnology industry. Nature Biotechnol. 14:1996;975-981.
50. Karlsson R., Falt A. Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J. Immunol. Methods. 200:1997;121-133.
51. Myszka D.G., Morton T.A. CLAMP: a biosensor kinetic data analysis program. Trends Biochem. Sci. 23:1998;149-150.
52. Shi J., Ghirlando R., Beavil R.L., Beavil A.J., Keown M.B., Young R.J. Interaction of the low-affinity receptor CD23/FcεRII lectin domain with the Fcε3-4 fragment of human immunoglobulin E. Biochemistry. 36:1997;2112-2122.
53. West A.P., Bjorkman P.J. Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor. Biochemistry. 39:2000;9698-9708.
54. Shopes B. Temperature-dependent binding of IgG1 to a human high affinity Fc receptor. Mol. Immunol. 32:1995;375-378.
55. Maenaka K., van der Merwe P.A., Stuart D.I., Jones E.Y., Sondermann P. The human low affinity Fcγ receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties. J. Biol. Chem. 276:2001;44898-44904.
56. Chapman T.L., You I., Joseph I.M., Bjorkman P.J., Morrison S.L., Raghavan M. Characterization of the interaction between the herpes simplex virus type I Fc receptor and immunoglobulin G. J. Biol. Chem. 274:1999;6911-6919.
57. Henry A.J., McDonnell J.M., Ghirlando R., Sutton B.J., Gould H.J. Conformation of the isolated Cε3 domain of IgE and its complex with the high-affinity receptor, FcεRI. Biochemistry. 39:2000;7406-7413.